Illumina – Grail deal: European investigation is not ‘nail in the coffin,’ Canaccord says

Georgejason/iStock Editorial via Getty Images

  • The European Commission (EC) has opened a full-scale investigation into the proposed acquisition of cancer test maker Grail (GRAL) by Illumina (ILMN +0.2%
    ), Reuters reported yesterday.
  • A decision on whether…

Click here to view the original article.